TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)
TWD 7.83
(-13.29%)
TWD 7.83
(-13.29%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -6.04 Million TWD | 93.46% |
| 2022 | -92.46 Million TWD | -644.44% |
| 2021 | -12.42 Million TWD | 70.74% |
| 2020 | -42.45 Million TWD | -735.27% |
| 2019 | -5.08 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -4.84 Million TWD | 0.0% |
| 2024 Q1 | -4.84 Million TWD | 46.39% |
| 2023 Q1 | 6.01 Million TWD | 114.5% |
| 2023 Q3 | -9.03 Million TWD | -250.3% |
| 2023 Q4 | -9.03 Million TWD | 0.0% |
| 2023 FY | -6.04 Million TWD | 93.46% |
| 2023 Q2 | 6.01 Million TWD | 0.0% |
| 2022 Q3 | -41.46 Million TWD | 0.0% |
| 2022 FY | -92.46 Million TWD | -644.44% |
| 2022 Q4 | -41.46 Million TWD | 0.0% |
| 2021 FY | -12.42 Million TWD | 70.74% |
| 2020 FY | -42.45 Million TWD | -735.27% |
| 2019 FY | -5.08 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 88.322% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 102.409% |
| Level Biotechnology Inc. | 62.9 Million TWD | 109.613% |
| Sagittarius Life Science Corp | -55.03 Million TWD | 89.013% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 90.646% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 96.896% |
| GlycoNex Incorporation | -178.36 Million TWD | 96.61% |
| VBI | -6.6 Million TWD | 8.393% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 96.363% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | 43.391% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | 84.159% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 96.402% |
| Visgeneer Inc. | -19.58 Million TWD | 69.131% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 99.114% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 100.966% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 108.352% |
| Neith Corporation | -40.03 Million TWD | 84.895% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 99.479% |
| Enimmune corporation | -223.74 Million TWD | 97.297% |
| TaiRx, Inc. | -212.29 Million TWD | 97.152% |
| CHO Pharma, Inc. | -306.08 Million TWD | 98.024% |
| EirGenix Inc. | -915.2 Million TWD | 99.339% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 112.156% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | 90.45% |
| Lin BioScience, Inc. | -687.19 Million TWD | 99.12% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 96.132% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 126.531% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 91.749% |
| Lukas Biomedical Inc. | -47.35 Million TWD | 87.23% |
| RBC Bioscience Corporation | 6.43 Million TWD | 194.044% |
| BiOptic Inc. | 37.74 Million TWD | 116.02% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 99.121% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | 83.729% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 90.174% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 102.2% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 93.435% |
| NaviFUS Corp. | -65.72 Million TWD | 90.8% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 93.135% |
| Sinew Pharma Inc. | -170.92 Million TWD | 96.462% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 91.128% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 104.628% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 97.46% |
| AP Biosciences Inc | -339.29 Million TWD | 98.218% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 98.923% |
| 3D Global Biotech Inc. | -57.95 Million TWD | 89.565% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 171.511% |
| Intech Biopharm Corporation | -337.98 Million TWD | 98.211% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 99.539% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 88.284% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 96.457% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 101.121% |
| TCI GENE Inc. | 11.67 Million TWD | 151.803% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 95.259% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 97.959% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 97.22% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 159.753% |
| PharmaEngine, Inc. | 274.65 Million TWD | 102.202% |
| Savior Lifetec Corporation | 30.03 Million TWD | 120.137% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 104.423% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 99.422% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 95.176% |
| Acepodia, Inc. | -817.31 Million TWD | 99.26% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 98.762% |